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Abstract 
The histone H2A variant H2AZ is an essential chromatin signaling factor. Herein, we report 
that H2AZ is mono-methylated at lysine 7 (H2AZK7me1) by the lysine methyltransferase SETD6. 
We observed that methylation of H2AZ increased noticeably upon cellular differentiation of 
mouse embryonic stem cells (mESC). H2AZK7me1 and the repressive H3K27me3 mark were 
found near the transcriptional start sites of differentiation marker genes, but were removed upon 
retinoic acid-induced cellular differentiation. The depletion of Setd6 in mESC led to cellular 
differentiation, compromised self-renewal, and poor clonogenicity. These findings demonstrate 
that mESC require Setd6 for self-renewal and portray H2AZK7me1 as a marker of cellular 
differentiation. 
Introduction 
The role of lysine methylation in human pathologies is highlighted by the increasing number 
of lysine methyltransferases (KMT) involved in the etiology of cancer,1, 2 growth defects,3, 4 and 
neurological disorders.5 Therefore, the identification and characterization of novel KMT 
substrates is postulated to be pivotal for the understanding of human pathologies. 
Our current knowledge of how H2AZ functions to regulate DNA-dependent cellular 
processes is limited. H2AZ is found at actively transcribed promoters in human cells,6 suggesting 
a role in favoring open chromatin conformations. Recently, a genome-wide study conducted in 
human cells by Valdés-Mora et al showed that the acetylated form of H2AZ was solely found at 
the transcriptional start site of actively expressed genes, while the deacetylated form of H2AZ 
localized at silenced promoters.7 Therefore, post-translational modifications appear to be a 
critical component of gene expression regulation by H2AZ. 
Embryonic stem cells (ESC) have the potential to differentiate and give rise to all the cell 
types constituting multi-cellular organisms, an aptitude known as pluripotency. ESC are also 
characterized by their ability to self-renew. It has been shown that murine ESC (mESC) cellular 
differentiation is prevented by silencing the expression of H2AZ.8 In addition, H2AZ colocalizes 
with the transcriptional silencing H3K27me3 mark and the PRC2 complex subunits SUZ12 and 
EED in mESC near the transcription start site of developmental genes.8, 9 However, although 
H2AZ is important for PRC2 chromatin association,8 PC2 subunits are dispensable for H2AZ 
nucleosome incorporation.10 
Herein, we demonstrate that SETD6 mono-methylates H2AZ on lysine 7 (H2AZK7me1) in 
vitro and that SETD6 contributes to H2AZ methylation in vivo. Mass spectrometric analysis 
detected lysine methylation of H2AZ on both lysine 4 and lysine 7 on in vitro methylated H2AZ 
as well as on endogenous H2AZ. A substantial increase of H2AZ lysine methylation upon mESC 
differentiation led us to investigate the potential role of Setd6 in stem cell biology. Depletion of 
Setd6 in mESC resulted in cellular differentiation, compromised self-renewal, and reduced 
clonogenicity. Finally, we observed that H2AZK7me1 was evicted along with the silencing mark 
H3K27me3 from the promoter of differentiation markers upon retinoic acid-induced cellular 
differentiation. 
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Results 
Identification of H2AZ lysine methyltransferases 
We hypothesized that H2AZ could be modified and regulated by lysine methylation. We thus 
fused the first 50 residues of H2AZ to the amino terminus of GST (H2AZWT50-GST; Figure 1A), 
which was then affinity purified and used as a substrate in an in vitro screen using a panel of 
KMTs, described previously.11 Each recombinant enzyme was incubated with H2AZWT50-GST in 
the presence of the tritiated form of the methyl donor S-adenosylmethionine (3H-SAM). H2AZ 
was methylated predominantly by SETD6 and SET7 (Figure 1B). These were then validated 
individually on purified full-length H2AZ containing a carboxy-terminal 6xHis tag and we 
confirmed that both SETD6 and SET7 methylated H2AZ (Figure 1C). These findings suggest 
that H2AZ is a bona fide substrate of SETD6 and SET7. 
H2AZ is methylated on lysines K4 and K7 in vitro 
To identify the precise lysine methylation site(s) on H2AZ, all amino terminal lysines were 
converted to arginines (R) to obtain an unmethylable H2AZ form (K0). Then, each R was 
individually converted back to K, so that H2AZ contained only one K that could be methylated 
(Figure 2A). These mutant forms of H2AZ were then subjected to KMT assays with either 
SETD6 or SET7. The K7K mutant was methylated by SETD6 to the same extent as the wild-
type form of H2AZ (WT50) (Figure 2B), suggesting that the SETD6-targeted methylation site is 
lysine 7. In a similar experiment, K13K appeared to be the major site for SET7 (Figure 2B). 
Subsequently, carboxy-terminally biotinylated and mono-, di-, or tri-methylated H2AZK7 
peptides were synthesized and subjected to in vitro methylation assays. These assays further 
demonstrate that H2AZ was effectively methylated by SETD6 (Figure 2C). In agreement with 
the results in Figure 2B, methylation of H2AZ by SETD6 was hindered by pre-methylation of 
K7, further suggesting that SETD6 methylates K7 of H2AZ. Specifically, the mono-methyl 
group on K7 impaired the methylation of the peptide by approximately 60%, while the dimethyl 
modestly impacted H2AZ methylation by an additional 10% decrease in activity, and the 
trimethyl had no further effect on SETD6 activity (Figure 2C). These results suggest that SETD6 
is capable of mono-methylating H2AZ. The residual KMT activity on the K7me2 and K7me3 
peptides (about 10 times above the no peptide (-) control background in Figure 2C) suggests that 
SETD6 may methylate secondary sites such as K4, as observed by a faint methylation signal on 
the recombinant K4K H2AZ-GST protein (Figure 2B). Equivalent amount of biotinylated 
peptides were used in the KMT assays (Figure S1A). In agreement with K7 being the major 
target site of SETD6, single mutation of K7 to an arginine led to a significant decrease in H2AZ 
methylation (Figure S1B). A similar experiment was also conducted with SET7 and the panel of 
K-R mutants. The latters were all methylated similarly to the wild-type H2AZ substrate (Figure 
S1B), suggesting that SET7 indiscriminately methylates multiple sites on H2AZ. Henceforth, we 
focused our efforts on H2AZK7me1 and SETD6, as little is known about post-translational 
modifications of H2AZ, especially lysine methylation, and SETD6 has no reported enzymatic 
activity on histones. 
Recombinant H2AZ was then in vitro methylated by SETD6 and analyzed by 
immunoblotting using our methyl-specific α-H2AZK7me1 antibody (Figure S2). The signal from 
the H2AZK7me1 antibody was substantially increased in the presence of H2AZ and SETD6 
(Figure 2D), convincingly indicating that SETD6 mono-methylates H2AZ. 
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To further confirm the site and state of methylation on H2AZ by SETD6, we conducted mass 
spectrometric (MS) analyses of KMT assays on biotinylated H2AZ peptides. These analyses 
showed that in vitro SETD6 catalyzes the mono-methylation of K7 (H2AZK7me1) while di-
methylation on K7 (H2AZK7me2) could not be detected on H2AZ peptides (Figure 2E). Also, 
low levels of H2AZ methylation were detected simultaneously on both K4 and K7. A detailed 
MS2 chromatogram highlights the mono-methylation of H2AZ at both K4 (molecular mass 
440.29) and K7 (molecular mass 766.49) (Figures 2F and S3). Importantly, mono-methylation on 
K7 was detected on two different peptides (molecular masses 766.49 and 1613.85 in Figure S3). 
Altogether, these results show that SETD6 preferentially mono-methylates H2AZK7 in vitro, but 
also methylates secondary sites, such as K4, as detected by mass spectrometric analyses. 
H2AZ is methylated on lysines K4 and K7 in vivo 
To confirm the biological existence of methyl-H2AZ, in vivo methylation of H2AZ was 
assessed by immunoblotting total protein lysates from control cells (LVTHM; parental shRNA 
control vector) and H2AZ depleted cells (shH2AZ). The unmodified-H2AZ and H2AZK7me1 
antibodies detected a decrease of H2AZ in the knockdown cell extract (Figure 3A). Importantly, 
cells depleted of SETD6 by two independent shRNAs (shSETD6 #7 and shSETD6 #10) had 
reduced levels of H2AZK7me1 (Figure 3B), suggesting that SETD6 mono-methylates H2AZ on 
lysine 7 in vivo. 
To detect dynamic changes in H2AZ lysine methylation in an in vivo biological system that 
requires H2AZ, we used an shRNA-mediated method12 (Figure S4A) for the depletion of Nanog 
(Figure 3C) and induction of mESC differentiation (Figures S4B and S4C). Subsequently, 
histones from mESCs were analyzed by MS to validate the existence of methyl-H2AZ in vivo. 
Interestingly, H2AZK7me1 was detected solely in conjunction with H2AZK4me1 (Figure 3D). But 
most importantly, methylation of H2AZ at K4 and K7 was increased by over 3-fold following 
mESC differentiation (Figures 3D and S4D). As observed with the shNanog-induced cellular 
differentiation system, induction of cellular differentiation by retinoic acid (RA) led to a 
noticeable increase in H2AZK7me1 and in H2AZK4me1K7me1 detected by immunoblotting of 
H2AZK7me1 (Figure 3E) and by mass spectrometry (Figure 3F), while the global levels of H2AZ 
and SETD6 appeared to diminish (Figure 3E). Together, these data demonstrate that H2AZ is 
mono-methylated in vivo on lysines K4 and K7. To conclude, the levels of H2AZK4me1K7me1 
increased noticeably in response to cellular differentiation induced by either RA or the silencing 
of Nanog expression. 
Since H2AZ is acetylated on lysines K4, K7, K11, K13, and K15,7, 13 we also investigated 
lysine acetylation during mESC differentiation. Interestingly, we observed that H2AZ acetylation 
at lysines K4, K7, and K11 increased substantially following Nanog depletion. Specifically, the 
mono- and di-acetylated forms increased by about 2-fold, from roughly 10% to 20% abundance 
and from approximately 2% to 4% abundance, respectively. However, the tri-acetylated 
(H2AZK4acK7acK11ac) form bolstered close to a 6-fold surge from a mere 0.15% to 0.8% 
abundance (Figure 3G). Since the MS analysis did not detect the presence of lysine acetylation 
and methylation simultaneously on the same peptide, our data indicate that the two modifications 
on H2AZ are mutually exclusive. 
SETD6 is required to maintain self-renewal of mESC 
Because of the compelling data showing an increase of H2AZK4me1K7me1 upon mESC 
differentiation, we further investigated the potential role of Setd6 and methyl-H2AZ in biological 
mESC properties. E14 mESC were transduced with shRNA-expressing lentiviral particles to 
target Setd6. While control cells retained mESC morphology, Setd6-depleted cells appeared 
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differentiated (Figure 4A). Specifically, Setd6 depletion induced a significant increase (p-value 
0.008) in partially and fully differentiated colonies accompanied by a drastic decrease (p-value 
0.01) in the undifferentiated colonies (Figure 4A). Setd6 depletion was validated by 
immunoblotting (Figure 4B) and differentiation of shSetd6 mESC confirmed by decreased 
Nanog level (Figure 4B). 
To further investigate the role of Setd6 expression in mESC biology, we conducted a 
competition assay, as described previously,12, 14, 15 in which mCherry-expressing (mCherry+) 
shLuc control or Setd6-depleted mCherry+ populations were each mixed with non-fluorescent 
mESC (Figure S5) and maintained over the course of 6 passages. The mixed populations were 
analyzed for mCherry signal by fluorescence-activated cell sorting (FACS) at each passage. This 
experiment demonstrates that self-renewal is compromised in the Setd6-depleted population 
(Figure 4C). Specifically, at passage 0 the population was composed of about 70% Setd6-
depleted cells, but these contributed to less than 25% of the population by passage 6 (Figures 4C 
and S5). Clonogenicity assays in which depletion of Setdb1 was used as a positive control,16 
confirmed that depletion of Setd6 led to impaired mESC self-renewal (Figure 4D). To refute the 
possibility that the impaired self-renewal of Setd6-depleted cells could be due to cell death, 
shSetd6 cells were stained for Annexin V (Figure S6). Also, the Setd6-depleted population had a 
normal cell cycle profile, which was measured by FACS (Figure S7), and unaltered proliferation 
capacity, which was assessed by Ki67 staining (Figure S8). These results reiterate16 and validate 
that Setd6 is required for mESC self-renewal. 
In response to Setd6 depletion, the expression of differentiation and pluripotency markers 
was analyzed and we found that Fgf5 was consistently and reproducibly upregulated (Figure 4E). 
The efficiency of Setd6 knockdown was also confirmed by qPCR (Figure 4E). These results 
suggest that Setd6 functions to maintain mESC self-renewal, presumably by repressing the 
expression of differentiation genes. 
To address the possibility that H2AZ and H2AZK7me1 could be involved in the regulation of 
Fgf5 expression, we induced E14 differentiation using retinoic acid (RA). We then investigated 
the incorporation of H2AZ forms at chromatin at the Fgf5 locus and found by chromatin 
immunoprecipitation assays that H2AZ was integrated within nucleosomes about 500 base pairs 
upstream of the Fgf5 transcriptional start site (TSS; Figure 4F) as well as at the TSS itself 
(Figure S9). However, H2AZK7me1 was enriched by about 3-fold at the -500 site and essentially 
absent from the TSS (Figures 4F and S9). Interestingly, upon RA-mediated differentiation, the 
levels of H2AZK7me1 dropped substantially in correlation with the loss of the epigenetic 
silencing mark H3K27me3 (Figure 4F). In addition, H2AZK7me1 was enriched at the TSS of 
FoxA2 (4-fold) and Hand2 (3-fold), but depleted along with H3K27me3 upon RA-mediated 
differentiation (Figure S9). The RA treatment also induced increased acetylation of the active 
transcription H3K9ac mark at the TSS of FoxA2 and Hand2 (Figure S9). 
Discussion 
Herein, we have identified two potent lysine methyltransferases, SETD6 and SET7, that 
modify the histone variant H2AZ. Although H2AZ is known to be poly-acetylated within the 
amino terminal tail (K4, K7, K11, K13, and K15)7, 13 as well as monoubiquitylated at the 
carboxy terminus (K120 and K121)17, 18 H2AZ had never been reported to be methylated. 
Interestingly, our methyl-specific H2AZK7me1 antibody detects a slow-migrating band (not 
shown), which, based on the observed molecular weight, is likely an ubiquitylated form of 
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H2AZ. These observations suggest that lysine methylation and ubiquitylation may occur together 
and that there could be some form of cross-talk between the two modifications. 
Regarding H2AZ acetylation, we anticipate that methylation of H2AZ at lysines 4 and 7 
could prevent subsequent acetylation at these sites, thereby impairing the reported transcriptional 
functions associated with the acetylation of H2AZ.7 Indeed, the mass spectrometry analysis did 
not detect any acetylation on the endogenous H2AZ. 
The mass spectrometry data from the shNanog and RA-treated cells, in addition to the data 
using our methyl-specific H2AZK7me1 antibody, highlight the authentic existence of a novel 
post-translational modification on H2AZ in human and murine cells. Interestingly, upon RA-
induced differentiation, H2AZK7me1 levels increased drastically although SETD6 decreased 
slightly at the protein level (Figure 3E) and mRNA level (not shown). It will be interesting to 
investigate if SETD6 enzymatic activity is increased upon RA treatment or whether other KMT 
are induced by RA. Indeed, we observed increased expression of several KMT in response to RA 
(not shown). Notably, SET7 mRNA levels increased by about two-fold in response to RA (not 
shown) and as a H2AZ methyltransferase may thus contribute to increased H2AZK7me1 levels. In 
future experiments, we will explore the contribution of these RA-induced KMT to H2AZ 
methylation. 
Hints of Setd6 potential role in mESC self-renewal surfaced in a genetic screen of chromatin 
factors.16 Our exhaustive investigations confirm through AP staining (Figure 4A), 
immnunoblotting of Nanog (Figure 4B), competition (Figure 4C) and clonogenic assays (Figure 
4D), as well as cell death assays (Figure S6) and cell cycle profiling (Figures S7 and S8) that 
Setd6 is required for mESC self-renewal. Since Setd6-depleted cells appear to differentiate, it 
will be interesting to investigate how Setd6 contributes to cell lineages and identify the types of 
differentiated cells that emerge from decreased Setd6 expression. Together with the ChIP 
analyses of H2AZ and H2AZK7me1 at Fgf5, FoxA2, and Hand2 promoters, these results suggest 
that Setd6 participates in the maintenance of mESC self-renewal by regulating the expression of 
differentiation markers such as Fgf5. In addition, the loss of both H2AZK7me1 and H3K27me3 
from Fgf5 upon cellular differentiation implies that H2AZK7me1 could be involved with 
H3K27me3 in an epigenetic program that regulates the expression of lineage commitment genes. 
Quite interestingly, although the global level of H2AZK7me1 increased upon RA-induced 
mESC differentiation, the level of H2AZK7me1 assessed at the promoters of Fgf5, FoxA2, and 
Hand2 decreased along with the H3K27me3 mark. Whether H2AZK7me1 is demethylated by a 
demethylase or evicted by an histone exchange complex remains to be uncovered. However, it is 
clear that H2AZK7me1 levels decrease at some promoters upon RA-induced differentiation. 
Genome-wide studies, such as H2AZ and H2AZK7me1 ChIPseq, may reveal more precisely their 
biological functions. In addition, the eventual identification of H2AZ- or H2AZK7me1-specific 
readers will undoubtedly help concretise the molecular mechanism of chromatin signaling by 
H2AZK7me1. 
To conclude, our results demonstrate that SETD6 mono-methylates H2AZ on lysine 7 and 
that H2AZ is methylated in vivo at lysines 4 and 7. Notably, the H2AZK4me1K7me1 mark is 
induced upon mESC cellular differentiation. Finally, we show that Setd6 is required for the 
maintenance of mESC self-renewal. Although H2AZK7me1 and H2AZK4me1K7me1 increased in 
differentiated mESC, the self-renewal defects we observed upon silencing of Setd6 are likely due 
to a combination of lysine methylation signaling events, including H2AZK7me1 and 
H2AZK4me1K7me1 as well as other SETD6 substrates, such as the NF-κB subunit, RelA.11 Future 
experiments should investigate the mechanism of H2AZK7me1 and H3K27me3 marks concomitant 
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loss from promoters and how these histone marks may cooperate to regulate the expression of 
differentiation genes and maintain mESC self-renewal potential. 
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Materials and Methods 
Plasmids, cDNA, and peptides. H2AZ cDNA was cloned from HeLa cells by PCR on reverse 
transcribed total RNA using Pfu SuperMix and SuperScript II Reverse Transcriptase, 
respectively (Invitrogen; cat. no. 12532-016 and 18064-022, respectively). The indicated H2AZ 
cDNAs were inserted in either pGEX6-P-1 (GE Healthcare; cat. no. 12532-016) or pET28 
(Novagen; cat. no. 69866-3) for bacterial expression. The H2AZ 
AGGKAGKme0/me1/me2/me3DSGKAKTKAVSRS-biotin and AGGKAGKme0/me1DSGKAKC 
peptides were synthesized at Yale University’s W.M. Keck Foundation Biotechnology Resource 
Laboratory. 
Cell culture. U2OS and HEK293T cell lines were maintained in D-MEM (HyClone). The 
mouse ES NanogR rescue cell line was maintained as previously described.12 E14 mESCs were 
maintained on 0.1% gelatin-coated tissue culture plates without feeder cells for all experiments. 
To induce differentiation with retinoic acid (RA), LIF (Chemicon; cat. no. ESG1107) was 
removed and RA (Sigma-Aldrich; cat. no. R2625) was added at a concentration of 5µM. 
Alkaline phosphatase activity was measured using a commercial detection kit (Sigma-Aldrich). 
Antibodies. The AGGKAGKme0/me1DSGKAKC peptides were conjugated to KLH (Sigma) 
according to the manufacturer’s suggested procedure, and used to immunize rabbits (Pocono 
Rabbit Farm and Laboratory, PA). An exhaustive list of the antibodies used can be found in the 
supplementary information. 
 
Full methods and associated references are available in the supplementary methods online. 
 
Supplementary information is available at Epigenetics online 
(http://www.landesbioscience.com/journals/epigenetics/). 
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Figure Legends 
Figure 1: Identification of H2AZ lysine methyltransferases. 
(A) Representation of H2AZWT50-GST. The first 50 amino acids of H2AZ were fused to the 
N-terminus of GST. (B) Autoradiogram of KMT assays using 3H-SAM, H2AZWT50-GST as a 
substrate, and the indicated KMTs. The enzymatic reactions were resolved by SDS-PAGE, 
transferred to PVDF, and either exposed on film (top) or probed with α-GST to show even 
H2AZ loading. (C) Validation of the potential H2AZ methyltransferases SETD6 and SET7. As 
in panel B, but full-length recombinant H2AZ-6xHis was used instead of H2AZWT50-GST as the 
substrate. 
Figure 2: H2AZ is methylated on lysines K4 and K7 in vitro. 
(A) Representation of the H2AZ mutants. Lysines are highlighted in red. (B) Autoradiogram 
of the KMT assays using SETD6 (top) or SET7 (bottom) and H2AZ mutants shown in panel A. 
(C) Flashplate KMT assays using SETD6 and indicated H2AZ-biotin peptides as substrates. 
Each condition was performed in quadruplicate and the error bars represent the standard error of 
the mean. The KMT activity is expressed as 3H counts per minute. (D) KMT assays on 
H2AZWT50-GST were analyzed by immunoblotting using the indicated antibodies. (E) Table 
summarizing the quantitative MS analysis of SETD6-methylated H2AZ-biotin peptide. (F) 
Chromatogram of the quantitative MS analysis performed to generate the table in panel E. The 
molecular weights of mono-methylated K4 and K7 peptides are highlighted (440.29 and 766.49, 
respectively). 
Figure 3: H2AZ is methylated on lysines K4 and K7 in vivo. 
(A) Protein extracts from U2OS control (LVTHM) or H2AZ knockdown (shH2AZ) cells 
were analyzed using the indicated methyl-specific antibody. (B) Lentiviruses were used to 
transduce U2OS cells to express the indicated human SETD6-targeting shRNAs and protein 
extracts were analyzed by immunoblotting using the indicated antibodies. (C) Immunoblot 
analysis of protein extracts from shNanog mESC shows loss of Nanog throughout the 
differentiation time course. (D) Quantitative MS analyses of the H2AZ peptides derived from 
differentiating mESC induced by Nanog knockdown at the indicated times. * denotes a p-value 
of 0.05. (E) Immunoblot analysis of H2AZK7me1 levels in untreated and RA-treated E14 cells. 
(F) Quantification by MS of total H2AZ, H2AZK7me1, and H2AZK4me1K7me1 from E14 mESC 
differentiated with RA. * and ** denote p-values of <0.05 and <0.02, respectively. (G) 
Quantification by MS of H2AZ acetylation in mESC during shNanog-induced differentiation 
shown as Abundance (left) and Fold increase (right). 
Figure 4: Setd6 maintains mESC self-renewal. 
(A) E14 mESC were transduced with either shLuc- or shSetd6-expressing lentiviral 
particules, selected with puromycin, and stained with alkaline phosphatase (AP). AP-stained 
colonies were scored as fully differentiated (FD), partially differentiated (PD), or 
undifferentiated (UD) according to the legend. * denotes a p-value of 0.008. (B) Setd6, Nanog, 
and Tubulin immunoblots from control and shSetd6 mESC. (C) Competition assay in which 
mCherry-expressing cells (shLuc or shSetd6) were mixed with control cells at a 4:1 ratio, 
maintained over the course of 6 passages, and monitored for mCherry expression by FACS. * 
denotes a p-value of <0.004. (D) Clonogenicity assays in which shLuc, shSetdb1, and shSetd6 
cells were plated at clonal density and stained for AP after 10 days. * denotes a p-value of 
<0.0002. (E) qPCR validation of Setd6 knockdown and analysis of Fgf5 expression. (F) ChIP 
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analysis of chromatin approximately 500 base pairs upstream of Fgf5 transcriptional start site 
(TSS) in undifferentiated mESC (E14) or retinoic acid-induced differentiated mESC (E14 +RA). 
The error bars represent the standard error of the mean calculated from a technical replicate 
triplicate from a representative biological replicate. * denotes a p-value of <0.02 between the IgG 
signal and H2AZK7me1 signal. ** denotes a p-value of <0.05 between the E14 untreated control 
and the E14 +RA samples. 
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